Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03188094 · ClinicalTrials.gov registry record · NA
Integrated Community-Clinical Linkage Model to Promote Weight Loss Among South Asians With Pre-Diabetes
A NA study of PreDiabetes and Weight Loss, sponsored by NYU Langone Health.
- Completed
- Registry status
- NA
- Development phase
- 974
- Enrollment target
- 1
- Study location
NCT03188094: Completed NA study of PreDiabetes and Weight Loss, sponsored by NYU Langone Health.
NCT03188094 is a NA study of PreDiabetes and Weight Loss that has completed, run by NYU Langone Health. The registered enrollment target is 974 participants, above the 695-participant average among 149 other PreDiabetes trials with a reported enrollment target (40% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03188094, a NA study of PreDiabetes and Weight Loss, has completed, sponsored by NYU Langone Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 974 participants
- Enrollment target
- 1
- Study location
Study Summary
The proposed study will inform efforts to prevent diabetes and promote weight loss in a high-risk population and generate a reproducible, scalable, and sustainable model for use with other insurer groups and clinical settings that work in immigrant populations with a high burden of chronic disease.
Primary Outcome
Weight measured at baseline and 6 month survey via study scale.
Conditions Studied
Interventions
- BEHAVIORAL CHW-Led Health Coaching
- OTHER EHR Alerts
Study Locations (1)
New York
- NYU Langone Health - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 974 participants |
| Start Date | 2018-12-17 |
| Est. Completion | 2024-06-30 |
| Phase | NA |
What the finished NCT03188094 record still lists
NCT03188094 is an interventional study that assigns participants to a tested intervention. The registered 974 participants enrollment target is mid-sized for trials with a published cap, above the 695-participant average among 149 other PreDiabetes trials with a reported enrollment target (40% higher).
The record links to 2 conditions, with PreDiabetes appearing as the primary indexed condition, and to 2 interventions - of which CHW-Led Health Coaching is the first listed.
NCT03188094 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT03188094 about?
NCT03188094 is a clinical study titled "Integrated Community-Clinical Linkage Model to Promote Weight Loss Among South Asians With Pre-Diabetes". The proposed study will inform efforts to prevent diabetes and promote weight loss in a high-risk population and generate a reproducible, scalable, and sustainable model for use with other insurer groups and clinical settings that work in immigrant populations with a high burden of chronic disease.
What is the current status of trial NCT03188094?
This trial is currently completed. It is a NA study. The enrollment target is 974 participants. The study started on 2018-12-17. Estimated completion is 2024-06-30.
What conditions does trial NCT03188094 study?
This clinical trial studies the following conditions: PreDiabetes, Weight Loss.
What interventions are being tested in trial NCT03188094?
The interventions under investigation include: CHW-Led Health Coaching (BEHAVIORAL), EHR Alerts (OTHER).
Who is sponsoring clinical trial NCT03188094?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03188094 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for PreDiabetes
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03188094's enrollment target sits among peer trials
974 12th of 149 higher than 138 of 149 other PreDiabetes trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other PreDiabetes trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Longitudinal Multi-Omic Profiles to Reveal Mechanisms of Obesity-Mediated Insulin Resistance
RECRUITING · NA
-
Black Impact: The Mechanisms Underlying Psychosocial Stress Reduction in a Cardiovascular Health Intervention
RECRUITING · NA
-
Diabetes Clinical Decision Support
RECRUITING · NA
-
Food as Medicine for HIV and Diabetes
RECRUITING · NA
-
Cleaner Air for Lower Cardiometabolic Risk
RECRUITING · NA
-
Strategies for Implementing a Postpartum Lifestyle Intervention in WIC Clinics
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06948422 · 974 participants · Phase 3
A Master Protocol for Orforglipron (LY3502970) in Participants With Hypertension and Obesity or Overweight: (ATTAIN-Hypertension Screening)
- NCT05600777 · 975 participants · Phase 3
A 24-Week Study of the Efficacy and Safety of BLU-5937 in Adults With Refractory Chronic Cough
- NCT06541704 · 975 participants · Phase 3
A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy
- NCT06820736 · 975 participants · NA
A Prospective, Randomized Comparison Of Drainage Techniques After One- Or Two-Level Open Posterior Lumbar Decompression Or Decompression And Fusion
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI